openPR Logo
Press release

Non-infectious Macular Edema Treatment Market to Incur High Value Growth at 7.0% CAGR During 2017-2026

Non-infectious Macular Edema Treatment Market to Incur High

The ophthalmology sector has gained massive traction during the course of the last few years. This is a result of growing prevalence of diseases like macular edema, which is a severe case of swelling in the retina possibly leading to blindness. Looking at the significant increase in the number of macular edema cases, many new drugs have been introduced in the global market and several are still in the pipeline. Anti-VEGF and corticosteroid therapies are considered to be the standard therapies for prevention of vision loss in patients in various indications of macular edema. The other drug types that are part of the macular edema treatment market are immunosuppressant and biologics, and many new treatment types are expected to be introduced as the market continues to grow. The outcomes of a recent market research by Persistence Market Research has revealed the growth of the global non-infectious macular edema treatment market at a CAGR of 7.0% during the forecast period 2018-2026. The study also projects the market to reach a valuation of over US$ 17,200 Mn by the end of 2026.

Increase in the Number of Combination Therapies to Boost Demand in the Global Market

Novel biological drugs are now being introduced owing to the increase in prevalence of macular edema cases. Even standard drugs such as Corticosteroids and anti-VEGF that are viewed as the first-line treatment for non-infectious macular edema are facing a limitation in use due to the associated side effects. This has given a leverage to companies to come up with other effective therapies. The new trends include a rise in the prescription of combination therapies that are more reliable in complex cases. This has increased the efficiency of the treatment process. An increase in the use of combination drugs is anticipated to spur demand in the non-infectious macular edema treatment market.

Request Sample Report@ https://www.persistencemarketresearch.com/samples/22984

Rate of Incidence of Macular Edema High in Europe Due to the Rising Prevalence of Diabetes

Diabetes related complications are one of the main causes of macular edema and there is a high rate of Diabetic Macular Edema (DME) in several countries across Europe. This makes the European market highly lucrative for manufacturers to introduce newer therapies and treatment options. However, the market forecast for the period of 2018-2026 projects North America to be the leading region in the global non-infectious macular edema treatment market with a valuation of over US$ 5,900 Mn by the end of 2026. In terms of growth rate, APAC is anticipated to exhibit growth at the fastest rate during the forecast period.

Request TOC@ https://www.persistencemarketresearch.com/methodology/22984

Competitive Landscape

Leading pharmaceutical and drug manufacturing companies from developed countries are investing substantially in R&D, infrastructure and new technologies in ophthalmology therapeutics to capture significant market share. Several companies are involved in mergers and acquisitions to design new and innovative treatment options for macular edema. Some of the leading companies that dominate the market currently include Allergan, Plc. Pfizer, Inc., Novartis AG, F. Hoffman - La Roche Ltd., AbbVie Inc. etc.

ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-infectious Macular Edema Treatment Market to Incur High Value Growth at 7.0% CAGR During 2017-2026 here

News-ID: 1190268 • Views:

More Releases from Persistence Market Research

Power Quality Equipment Market Size to Reach US$54.2 Billion by 2032, Driven by Rising Demand for Reliable Power Supply
Power Quality Equipment Market Size to Reach US$54.2 Billion by 2032, Driven by …
Market Overview The global power quality equipment market is witnessing significant growth as industries, utilities, and commercial sectors increasingly emphasize uninterrupted and reliable electricity supply. According to Persistence Market Research's projections, the market size is expected to be valued at US$35.8 billion in 2025 and is projected to reach US$54.2 billion by 2032, expanding at a CAGR of 6.1% during the forecast period. This growth is fueled by rapid industrialization, rising
Anaerobic Adhesives Market Size to Reach US$894.5 Million by 2031, Driven by Expanding Industrial Applications and Demand for High-Performance Bonding Solutions
Anaerobic Adhesives Market Size to Reach US$894.5 Million by 2031, Driven by Exp …
Market Overview The global anaerobic adhesives market is experiencing steady growth as industries increasingly adopt advanced bonding solutions that enhance durability, reliability, and performance. According to Persistence Market Research's projections, the market is estimated to rise from US$613.9 million in 2024 to US$894.5 million by 2031, expanding at a CAGR of 5.5% during the forecast period. This growth is fueled by the rising demand from sectors such as automotive, aerospace, electronics,
Textile Coatings Market Size to Reach US$6.8 Billion by 2031, Fueled by Demand for Functional and Durable Fabrics
Textile Coatings Market Size to Reach US$6.8 Billion by 2031, Fueled by Demand f …
Market Overview The global textile coatings market is witnessing steady growth, driven by the rising demand for functional, durable, and performance-enhancing fabrics across industries such as automotive, construction, healthcare, and fashion. According to Persistence Market Research's projections, the market is estimated to increase from US$4.8 billion in 2024 to US$6.8 billion by 2031, expanding at a CAGR of 5.0% during the forecast period. This growth is underpinned by the increasing adoption
Architectural LED Products Market to Reach $23.6 Bn by 2032 Driven by Energy-Efficient Lighting Demand
Architectural LED Products Market to Reach $23.6 Bn by 2032 Driven by Energy-Eff …
The global architectural LED products market is poised for substantial expansion over the next decade. Valued at approximately USD 12.5 billion in 2025, the market is projected to reach USD 23.6 billion by 2032, reflecting a robust compound annual growth rate (CAGR) of 9.4% during the forecast period from 2025 to 2032. This growth trajectory underscores the increasing adoption of LED technologies across residential, commercial, and industrial sectors, driven by

All 5 Releases


More Releases for Macular

2025-2034 Macular Edema and Macular Degeneration Market Roadmap: Insights for Co …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts How Large Will the Macular Edema and Macular Degeneration Market Size By 2025? In the past few years, the market size for macular edema and macular degeneration has seen significant growth. It is projected to increase from $9.65 billion in 2024 to $10.43 billion in 2025, exhibiting a compound
Macular Edema and Macular Degeneration Market Poised for 7.1% Growth, Set to Hit …
How Are the key drivers contributing to the expansion of the macular edema and macular degeneration market? The growth of the macular edema and macular degeneration market is predicted to be driven by the escalating number of individuals suffering from diabetes. Diabetes is a long-term health condition that results in elevated levels of glucose in the bloodstream. The condition harms the eye's blood vessels, potentially leading to macular edema and macular
Macular Edema and Macular Degeneration Market Outlook 2025-2034: Key Trends, Gro …
"How Big Is the Macular Edema and Macular Degeneration Market Expected to Be, and What Will Its Growth Rate Be? The macular edema and macular degeneration market has seen significant growth in recent years. It will expand from $9.65 billion in 2024 to $10.43 billion in 2025, with a CAGR of 8.1%. Factors contributing to this growth include the aging population, increasing diabetes prevalence, early diagnosis and awareness, global initiatives in
Macular Edema and Macular Degeneration Market to Reach $22.51 Billion by 2034
The global macular edema and macular degeneration market, valued at $10.33 billion in 2023, is on track to grow at a remarkable compound annual growth rate (CAGR) of 7.34%, reaching $22.51 billion by 2034. This substantial market expansion is being fueled by rising treatment innovations, an increasing global prevalence of related diseases, and a surge in technological advancements in diagnostics and therapies. Download White Paper: https://www.towardshealthcare.com/download-statistics/5375 Market Overview and Key Drivers The macular
Macular Edema and Macular Degeneration Market Size, Trends, Growth, Outlook 2024 …
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Macular Edema and Macular Degeneration Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $12.84
Macular Edema and Macular Degeneration Market: Key Trends, Competitor Analysis, …
"Exploring the Global Macular Edema and Macular Degeneration Market: A Comprehensive Overview Insights into Macular Edema and Macular Degeneration Market: Global Trends and Analysis Macular Edema and Macular Degeneration Industry - Key Market Dynamics and Trends The macular edema and macular degeneration market size has grown strongly in recent years. It will grow from $8.84 billion in 2023 to $9.65 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The